Načítá se...
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers
BACKGROUND: Molecular biomarkers, a cornerstone of precision oncology, are critical in breast, gastroesophageal, and non–small cell lung cancer management (BC, GEC, NSCLC). Testing practices are intensely debated, impacting diagnostic quality and affecting pathologists, oncologists and patients. How...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4176043/ https://ncbi.nlm.nih.gov/pubmed/25217578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju256 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|